Update your browser

Your browser (Internet Explorer) is out of date.

Update your browser for more security, comfort and the best experience on this site.

Edison Pharmaceuticals, Inc.

Edison is a world leader in the discovery and development of redox drugs. The company has obtained orphan designation in both the United States and Europe for its first drug candidate.

350 North Bernardo Avenue, Mountain View, CA 94043, United States

Profile Navigation
This is a community generated profile. If you would like to claim it, please contact us.

About

Our Company

Edison is a world leader in the discovery and development of redox drugs. The company has obtained orphan designation in both the United States and Europe for its first drug candidate, EPI-743 (Vincerinone®). Vincerinone® is now in phase 2 clinical development. It is being evaluated in multiple clinical indications where defects in the mitochondrial proteins and redox control have been well characterized.

Markets

areas of proficiency

Company Type

Choose Company Type

Cancel

Company Size

< 10

Choose Company Size

Cancel

Contact Info

get in touch

  • Location:

    Other: 350 North Bernardo Avenue, Mountain View, CA 94043, United States